Epidemiology, Risk Factors, and Clinical Features of Intracerebral Hemorrhage: An Update - PubMed (original) (raw)
Review
Epidemiology, Risk Factors, and Clinical Features of Intracerebral Hemorrhage: An Update
Sang Joon An et al. J Stroke. 2017 Jan.
Abstract
Intracerebral hemorrhage (ICH) is the second most common subtype of stroke and a critical disease usually leading to severe disability or death. ICH is more common in Asians, advanced age, male sex, and low- and middle-income countries. The case fatality rate of ICH is high (40% at 1 month and 54% at 1 year), and only 12% to 39% of survivors can achieve long-term functional independence. Risk factors of ICH are hypertension, current smoking, excessive alcohol consumption, hypocholesterolemia, and drugs. Old age, male sex, Asian ethnicity, chronic kidney disease, cerebral amyloid angiopathy (CAA), and cerebral microbleeds (CMBs) increase the risk of ICH. Clinical presentation varies according to the size and location of hematoma, and intraventricular extension of hemorrhage. Patients with CAA-related ICH frequently have concomitant cognitive impairment. Anticoagulation related ICH is increasing recently as the elderly population who have atrial fibrillation is increasing. As non-vitamin K antagonist oral anticoagulants (NOACs) are currently replacing warfarin, management of NOAC-associated ICH has become an emerging issue.
Keywords: Cerebral hemorrhage; Epidemiology; Incidence; Neurologic manifestations; Risk factors.
Conflict of interest statement
The authors have no financial conflicts of interest.
Similar articles
- Association of Intracerebral Hemorrhage Among Patients Taking Non-Vitamin K Antagonist vs Vitamin K Antagonist Oral Anticoagulants With In-Hospital Mortality.
Inohara T, Xian Y, Liang L, Matsouaka RA, Saver JL, Smith EE, Schwamm LH, Reeves MJ, Hernandez AF, Bhatt DL, Peterson ED, Fonarow GC. Inohara T, et al. JAMA. 2018 Feb 6;319(5):463-473. doi: 10.1001/jama.2017.21917. JAMA. 2018. PMID: 29372247 Free PMC article. - The Clinical Dilemma of Anticoagulation Use in Patients with Cerebral Amyloid Angiopathy and Atrial Fibrillation.
Cannistraro RJ, Meschia JF. Cannistraro RJ, et al. Curr Cardiol Rep. 2018 Sep 12;20(11):106. doi: 10.1007/s11886-018-1052-1. Curr Cardiol Rep. 2018. PMID: 30209626 Review. - Time in therapeutic range of anticoagulation among patients with atrial fibrillation and cerebral amyloid angiopathy.
Ward RC, Graff-Radford J, Ponamgi S, English S, Meskill A, Challa AB, Hodge DO, Slusser JP, Rabinstein AA, Asirvatham SJ, Holmes D Jr, DeSimone CV. Ward RC, et al. Proc (Bayl Univ Med Cent). 2021 Dec 28;35(2):162-167. doi: 10.1080/08998280.2021.2013393. eCollection 2022. Proc (Bayl Univ Med Cent). 2021. PMID: 35261442 Free PMC article. - Cerebral amyloid angiopathy-associated intracerebral hemorrhage: pathology and management.
Mehndiratta P, Manjila S, Ostergard T, Eisele S, Cohen ML, Sila C, Selman WR. Mehndiratta P, et al. Neurosurg Focus. 2012 Apr;32(4):E7. doi: 10.3171/2012.1.FOCUS11370. Neurosurg Focus. 2012. PMID: 22463117 Review. - Risk of intracranial hemorrhage in patients using anticoagulant therapy for atrial fibrillation after cerebral microbleeds combined with acute ischemic stroke: a meta-analysis.
Zhao B, Yuan Y, Li Z, Chen Y, Gao Y, Yang B, Wu J, Jia W. Zhao B, et al. Front Neurol. 2024 Mar 15;15:1372231. doi: 10.3389/fneur.2024.1372231. eCollection 2024. Front Neurol. 2024. PMID: 38560733 Free PMC article. Review.
Cited by
- Hematoma Expansion in Intracerebral Hemorrhage: An Update on Prediction and Treatment.
Li Z, You M, Long C, Bi R, Xu H, He Q, Hu B. Li Z, et al. Front Neurol. 2020 Jul 17;11:702. doi: 10.3389/fneur.2020.00702. eCollection 2020. Front Neurol. 2020. PMID: 32765408 Free PMC article. Review. - CircRNA and Stroke: New Insight of Potential Biomarkers and Therapeutic Targets.
Chen XL, Tan QD, Chen KJ, Zheng DN, Deng HW, He S, Mao FK, Hao JL, Le WD, Yang J. Chen XL, et al. Neurochem Res. 2024 Mar;49(3):557-567. doi: 10.1007/s11064-023-04077-6. Epub 2023 Dec 8. Neurochem Res. 2024. PMID: 38063946 Review. - A Brazilian series utilizing the SMASH-U system for etiologic classification of intracerebral hemorrhage.
Silva LHL, Andrade JBC, Majdoub AAE, Miranda-Alves M, Valiente RA, Rodrigues DLG, Silva GS. Silva LHL, et al. Arq Neuropsiquiatr. 2024 Jan;82(1):1-7. doi: 10.1055/s-0044-1779505. Epub 2024 Feb 5. Arq Neuropsiquiatr. 2024. PMID: 38316424 Free PMC article. - Mortality and morbidity in patients with spontaneous intracerebral hemorrhage: A single-center experience.
Faghih-Jouybari M, Raof MT, Abdollahzade S, Jamshidi S, Padegane T, Ehteshami S, Fateh S. Faghih-Jouybari M, et al. Curr J Neurol. 2021 Jan 4;20(1):32-36. doi: 10.18502/cjn.v20i1.6377. Curr J Neurol. 2021. PMID: 38011469 Free PMC article. - Microglial pyroptosis: Therapeutic target in secondary brain injury following intracerebral hemorrhage.
Gu L, Sun M, Li R, Tao Y, Luo X, Zhang X, Yuan Y, Xie Z. Gu L, et al. Front Cell Neurosci. 2022 Sep 9;16:971469. doi: 10.3389/fncel.2022.971469. eCollection 2022. Front Cell Neurosci. 2022. PMID: 36159393 Free PMC article. Review.
References
- Qureshi AI, Tuhrim S, Broderick JP, Batjer HH, Hondo H, Hanley DF. Spontaneous intracerebral hemorrhage. N Engl J Med. 2001;344:1450–1460. - PubMed
- Garcia JH, Ho KL. Pathology of hypertensive arteriopathy. Neurosurg Clin N Am. 1992;3:497–507. - PubMed
- Krishnamurthi RV, Moran AE, Forouzanfar MH, Bennett DA, Mensah GA, Lawes CM, et al. The global burden of hemorrhagic stroke: a summary of findings from the GBD 2010 study. Glob Heart. 2014;9:101–106. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials